A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Trishula Therapeutics, Inc.
Eli Lilly and Company
NanOlogy, LLC
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
University of California, Davis
Hoosier Cancer Research Network
Merck Sharp & Dohme LLC
Hoffmann-La Roche
University of Chicago
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Stanford University
Case Comprehensive Cancer Center